Peak flow variability, methacholine responsiveness and atopy as markers for detecting different wheezing phenotypes in childhood

R T Stein, C J Holberg, W J Morgan, A L Wright, E Lombardi, L Taussig, F D Martinez, R T Stein, C J Holberg, W J Morgan, A L Wright, E Lombardi, L Taussig, F D Martinez

Abstract

Background: There is increasing evidence that wheezing during childhood may be a heterogeneous condition, and that different forms of wheezing may be associated with different risk factors and prognosis. The aim of this study was to determine if measures of airway lability and of atopy could identify distinct wheezing phenotypes during childhood.

Method: In a cohort of children followed from birth peak flow variability (n = 600) was evaluated and methacholine challenge responsiveness (n = 397) was measured at age 11 in relation to wheezing before the age of three, and at age six and 11 years total serum IgE and skin test reactivity to allergens were determined.

Results: Neither positive peak flow variability nor methacholine hyperresponsiveness measured at age 11 were associated with wheezing occurring only during the first three years of life. Both methacholine hyperresponsiveness and positive peak flow variability were associated with wheezing at both ages six and 11 (OR 5.1 (95% CI 2.4 to 10.6) and 2.3 (1.2 to 4.5), respectively). In addition, positive peak flow variability was associated with wheezing up to the age of six but not at age 11 in non-atopic children (OR 2.9 (95% CI 1.0 to 8.8)). Methacholine hyperresponsiveness measured at age 11 was more frequently observed in boys (OR 2.1 (95% CI 1.2 to 3.5)) and was strongly associated with serum IgE levels measured at ages six and 11 (p < 0.001) and with positive skin test reactivity (OR 4.5 (95% CI 2.0 to 10.1)). Peak flow variability was unrelated to sex or markers of atopy (IgE and skin test reactivity).

Conclusions: Methacholine responsiveness and peak flow variability assessed at age 11, together with markers of atopy (IgE and skin test reactivity to allergens) identify three different wheezing phenotypes in childhood: "transient early wheezing" limited to the first three years of life and unrelated to increased airway lability; "non-atopic wheezing" of the toddler and early school years associated with positive peak flow variability but not with methacholine hyperresponsiveness; and "IgE-associated wheeze/asthma" associated with persistent wheezing at any age and with methacholine hyperresponsiveness, peak flow variability, and markers of atopy.

References

    1. Arch Dis Child. 1989 Aug;64(8):1126-32
    1. Am Rev Respir Dis. 1991 Apr;143(4 Pt 1):755-60
    1. Thorax. 1983 Oct;38(10):760-5
    1. Am Rev Respir Dis. 1986 Nov;134(5):994-8
    1. Clin Allergy. 1987 Jul;17(4):271-81
    1. Am Rev Respir Dis. 1988 Feb;137(2):302-7
    1. Thorax. 1989 Mar;44(3):168-76
    1. Am J Epidemiol. 1989 Jun;129(6):1219-31
    1. Am J Epidemiol. 1989 Jun;129(6):1232-46
    1. Am Rev Respir Dis. 1989 Aug;140(2):350-7
    1. Am Rev Respir Dis. 1989 Nov;140(5):1368-72
    1. Am Rev Respir Dis. 1991 Feb;143(2):312-6
    1. Am Rev Respir Dis. 1991 Feb;143(2):323-30
    1. Am J Respir Crit Care Med. 1996 Sep;154(3 Pt 1):670-80
    1. Am Rev Respir Dis. 1991 May;143(5 Pt 1):916-21
    1. Clin Exp Allergy. 1991 Mar;21(2):235-41
    1. N Engl J Med. 1991 Oct 10;325(15):1067-71
    1. Am Rev Respir Dis. 1991 Nov;144(5):1012-5
    1. Clin Exp Allergy. 1991 Nov;21(6):753-6
    1. Ann Allergy. 1992 Mar;68(3):261-6
    1. Am Rev Respir Dis. 1992 Mar;145(3):588-93
    1. J Allergy Clin Immunol. 1992 Sep;90(3 Pt 1):376-85
    1. Am J Respir Crit Care Med. 1994 Mar;149(3 Pt 1):598-603
    1. Thorax. 1995 Apr;50(4):339-45
    1. Thorax. 1995 Oct;50(10):1027-30
    1. Thorax. 1996 May;51(5):503-509

Source: PubMed

3
Se inscrever